BioMarin to Participate in Two Upcoming Virtual Investor Conferences
- 7th Annual Truist Securities Life Sciences Summit on May 4 at 1:50pm ET - BofA 2021 Health Care Conference on May 11 at 2:00pm ET
Get Alerts BMRN Hot Sheet
Join SI Premium – FREE
SAN RAFAEL, Calif., May 3, 2021 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in two upcoming virtual conferences. An audio webcast of the presentations will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.
About BioMarin
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.
For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.
Contacts: | |
Investors | Media |
Traci McCarty | Debra Charlesworth |
BioMarin Pharmaceutical Inc. | BioMarin Pharmaceutical Inc. |
(415) 455-7558 | (415) 455-7451 |
View original content to download multimedia:http://www.prnewswire.com/news-releases/biomarin-to-participate-in-two-upcoming-virtual-investor-conferences-301281668.html
SOURCE BioMarin Pharmaceutical Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Steel Dynamics Reports First Quarter 2024 Results
- UBS Reiterates Buy Rating on BioMarin Pharmaceutical Inc. (BMRN)
- Peapack-Gladstone Financial Corporation Reports First Quarter Results
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!